The Evolution of Drug Regulatory Sciences in the Netherlands:More than a Country Report

In the Netherlands, drug regulatory science is a vibrant national and internationally oriented community. In this review, we present the factors that have contributed to this successful collaboration between relevant stakeholders and that led to a surge of activities around how regulatory science became embedded in the ecosystem of medicines research, clinical pharmacology, policymaking and regulation. We distinguished three pivotal episodes: (i) TI Pharma Escher-project, (ii) Dutch Medicines Evaluation Board as catalyst of the big jump, and (iii) Regulatory Science Network Netherlands and mul... Mehr ...

Verfasser: Pasmooij, Anna M.G.
Mol, Peter G.M.
Bot, Jacob Cornelis
Leufkens, Hubert G.M.
Dokumenttyp: Artikel
Erscheinungsdatum: 2024
Reihe/Periodikum: Pasmooij , A M G , Mol , P G M , Bot , J C & Leufkens , H G M 2024 , ' The Evolution of Drug Regulatory Sciences in the Netherlands : More than a Country Report ' , Clinical Pharmacology and Therapeutics , vol. 116 , no. 1 , pp. 64-71 . https://doi.org/10.1002/cpt.3275
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29190813
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/11370/43ce884d-bc54-490d-b65f-a0131628e103